Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urocanic acid isomerization" refers to the **conversion between the trans and cis forms of urocanic acid**, a naturally occurring metabolite found predominantly in the stratum corneum of human skin. The most biologically relevant process is the **photoisomerization** from trans‑urocanic acid to cis‑urocanic acid upon exposure to ultraviolet B (UVB) radiation. This reaction does not refer to a specific protein, receptor, or drug target but rather describes a chemical transformation that can occur spontaneously under UV light or be catalyzed by certain microbial enzymes such as *cis*-UCA isomerase in some bacteria[3][6]. Trans‑urocanic acid acts as an endogenous sunscreen, absorbing UVB and protecting against DNA damage; its photoisomerized product, *cis*-urocanic acid, has been shown to activate regulatory T cells and contribute to immunosuppression following sun exposure[1][3]. The balance between these two forms may influence susceptibility to immune-mediated skin conditions. In clinical biochemistry, measurement of this ratio serves as a sensitive indicator for suberythemal UVB doses and sunscreen efficacy assessment[1]. Because "Urocanic acid isomerization" describes a **chemical process** rather than an individual molecular target such as an enzyme or receptor, it should not be considered a therapeutic target itself. Instead, enzymes involved in its metabolism—such as histidine ammonia lyase or microbial *cis*-UCA isomerases—are more appropriate molecular targets if relevant for research purposes[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urocanic acid isomerization.